Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-05-15

Clinical Trial Update: Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer [Phase 3]

View source ↗

Summary

This document reports an ongoing Phase 3 randomized trial comparing weekly versus 3-weekly cisplatin regimens for locally advanced cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Locally Advanced Cervical Cancer | Phase 3 | Status: UNKNOWN